 |
|
|
|
|
|
 Introduction
Human
Veterinary
Environmental
Industrial
Agricultural
MSG
Introduction
Medical
Veterinary
Environmental
Industrial
Agricultural
Introduction
Susceptibility
MIC Database
Procedures
Histopathology
Introduction
Abbreviations
Links
CME
Conference
Highlights
Bibliography
Glossary
Good Books
Events Calendar
Introduction
Our Mission
Editorial Board
Editorial Staff
Supporters
Contributors
Legal Stuff
Privacy Policy
Kudos
Introduction
Descriptions
Synonyms
Image Bank
Lecture Bank
Video Bank
This page updated:
1/27/2007 9:23:00 AM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
|
|
You are here:
The Fungi
> Descriptions >
|
Paracoccidioides sp.
de Almeida, 1930
|  |
Kingdom: Fungi
Phylum: Ascomycota
Subphylum: Ascomycotina
Genus: Paracoccidioides
Paracoccidioides is a thermally dimorphic fungus. Although it has been isolated from soil and digestive tract of some animals, its natural habitat remains unknown. It mostly resides in soil which is humid and rich in proteins. It has been cultivated from fruit bats and armadillos. While the epidemiology of the infections due to Paracoccidioides has not been fully clarified, most infections with Paracoccidioides have been reported from Central and South America, particularly from Brazil, Venezuela, and Colombia. Geographic discrimination of the strains have recently been possible by randomly amplified polymorphic DNA analysis [363] [462, 2107, 2144, 2202].
The genus Paracoccidioides contains one species, Paracoccidioides brasiliensis. It is a mitosporic fungus and has no known teleomorph.
See the summary of synonyms and teleomorph-anamorph relations for the Paracoccidioides sp.
Paracoccidioides brasiliensis is the causative agent of a true systemic (endemic) mycosis called paracoccidioidomycosis. The spectrum of the disease is wide, varying from an asymptomatic infection verified by the skin test to a subclinical, symptomatic or chronic infection. Diagnosis of paracoccidioidomycosis is often difficult. The infection may become apparent several years after exposure to Paracoccidioides brasiliensis, suggesting the possibility of a long latent period. The infection is presumably acquired via inhalation of the conidia, followed by primary infection of the lungs. The degree of pathogenicity may vary and appears strain-dependent. An exocellular serine-thiol proteinase enzyme is a significant virulence factor of the fungus for tissue invasion. In addition to the primary pulmonary form of the disease, acute pulmonary, chronic pulmonary, and disseminated forms may also be observed. In cases of disseminated paracoccidioidomycosis, reticuloendothelial system, skin and mucous membranes are frequently involved. Lymph nodes may also be infected during the course of the infection. Aortitis may develop [462, 1430, 1557, 1851, 1896, 2202].
Given the true systemic nature of paracoccidioidomycosis, otherwise healthy individuals are affected. Acute pulmonary and disseminated paracoccidioidomycosis may rarely develop in immunocompromised host [462].
Being a thermally dimorphic fungus, Paracoccidioides brasiliensis grows in mould form at 25°C and in its yeast form at 37°C. Below are its macroscopic characteristics at varying temperatures [1295, 2144, 2202].
AT 25°C
Colonies are filamentous, slow growing, leathery, flat to wrinkled, woolly, cottony or glabrous to velvety. The colony matures and its diameter reaches to 1 to 2 cm in 2 to 3 weeks. The front color is white cream, tan or brown and the reverse color is yellowish brown to brown.
AT 37°C
Colonies are yeast-like, white, heaped, wrinkled or folded. Mould to yeast conversion usually occurs on enriched medium, such as brain heart infusion agar and following 10 to 20 days of incubation.
For definitive identification of the fungus, mould-to-yeast conversion should be demonstrated.
AT 25°C
It produces hyaline, septate hyphae and aleuriconidia. The hyphae are often sterile and do not sporulate. If present, conidia are oval, unicellular, truncate and with a broad base and rounded apex. They are located along the hyphae. Arthroconidia and intercalary chlamydospores may also be observed.
AT 37°C
It produces typical multiple buds which surround the whole surface of the mother yeast cell. This appearance resembles a steering-wheel. The daughter cell (bud) is attached to the mother cell by a narrow neck portion. Before the bud is detached from the mother cell, secondary buds may form, producing short chains of yeast cells.
[1295, 2144, 2202].
See our histopathology page.
Blastomyces dermatitidis
When only single buds are observed and multiple buds are not visible, Paracoccidioides brasiliensis needs to be differentiated from Blastomyces dermatitidis. In contrast to Paracoccidioides brasiliensis, the buds of Blastomyces dermatitidis are broad-based.
Cross-antigenicity has been detected between Paracoccidioides brasiliensis and Loboa loboi [365].
Although most strains are sterile and do not sporulate, it is in general accepted that isolates of Paracoccidioides brasiliensis must be handled with caution in a biological safety cabinet.
In vitro data on susceptibility profile of Paracoccidioides brasiliensis are limited. There is as yet no reference method standardized for this purpose and the methods that have been used for susceptibility testing also vary, making meaningful comparisons difficult. In general, relatively low MICs have been detected for amphotericin B, ketoconazole, itraconazole, fluconazole, and voriconazole tested against yeast phase of Paracoccidioides brasiliensis [965, 966, 1152]. However, higher itraconazole and fluconazole values have been reported for some isolates in another study [1493]. High MICs were obtained also for cilofungin, the first echinocandin [982].
For MICs of various antifungal drugs so far reported for Paracoccidioides brasiliensis, see our susceptibility database.
While amphotericin B, sulphonamides, and ketoconazole have been used for treatment of paracoccidioidomycosis, itraconazole now appears as the drug of choice [328, 1394].
PubMed
GenBank
|
Yeast phase of P. brasiliensis |
KOH preparation of a specimen with P. brasiliensis
(Image courtesy of Julio Garcia)
|
|
|
References
328. Brummer, E., E. Castaneda, and A. Restrepo. 1993. Paracoccidioidomycosis: An update. Clin. Microbiol. Rev. 6:89-117.
363. Calcagno, A. M., G. Nino-Vega, F. San-Blas, and G. San-Blas. 1998. Geographic discrimination of Paracoccidioides brasiliensis strains by randomly amplified polymorphic DNA analysis. J Clin Microbiol. 36:1733-1736.
365. Camargo, Z. P., R. G. Baruzzi, S. M. Maeda, and M. C. Floriano. 1998. Antigenic relationship between Loboa loboi and Paracoccidioides brasiliensis as shown by serological methods. Med Mycol. 36:413-417.
462. Collier, L., A. Balows, and M. Sussman. 1998. Topley & Wilson's Microbiology and Microbial Infections, 9th ed, vol. 4. Arnold, London, Sydney, Auckland, New York.
965. Hahn, R. C., and J. S. Hamdan. 2000. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis. Antimicrob. Agents Chemother. 44:1997-2000.
966. Hahn, R. C., and J. S. Hamdan. 2000. In vitro susceptibilities of Paracoccidioides brasiliensis yeast form to antifungal drugs. Mycoses. 43:403-407.
982. Hanson, L. H., and D. A. Stevens. 1989. Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrob. Agents Chemother. 33:1391-2.
1152. Kappe, R. 1999. Antifungal activity of the new azole UK-109, 496 (voriconazole). Mycoses. 42:83-86.
1295. Larone, D. H. 1995. Medically Important Fungi - A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.
1394. Lyman, C. A., and T. J. Walsh. 1992. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs. 44:9-35.
1430. Manns, B. J., B. W. Baylis, S. J. Urbanski, A. P. Gibb, and H. R. Rabin. 1996. Paracoccidioidomycosis: case report and review. Clin Infect Dis. 23:1026-32.
1493. McGinnis, M. R., L. Pasarell, D. A. Sutton, A. W. Fothergill, C. R. Cooper, Jr., and M. G. Rinaldi. 1997. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob. Agents Chemother. 41:1832-1834.
1557. Molinari-Madlum, E., M. S. S. Felipe, and C. M. A. Soares. 1999. Virulence of Paracoccidioides brasiliensis isolates can be correlated to groups defined by random amplified polymorphic DNA analysis. Med Mycol. 37:269-276.
1851. Puccia, R., A. K. Carmona, J. L. Gesztesi, L. Juliano, and L. R. Travassos. 1998. Exocellular proteolytic activity of Paracoccidioides brasiliensis: cleavage of components associated with the basement membrane. Med Mycol. 36:345-348.
1896. Restrepo, A., C. de Bedout, L. E. Cano, M. D. Arango, and V. Bedoya. 1981. Recovery of Paracoccidioides brasiliensis from a partially calcified lymph node lesion by microaerophilic incubation of liquid media. Sabouraudia. 19:295-300.
2107. Silva-Vergara, M. L., R. Martinez, Z. P. Camargo, M. H. Malta, C. M. Maffei, and J. B. Chadu. 2000. Isolation of Paracoccidioides brasiliensis from armadillos (Dasypus novemcinctus) in an area where the fungus was recently isolated from soil [In Process Citation]. Med Mycol. 38:193-9.
2144. St-Germain, G., and R. Summerbell. 1996. Identifying Filamentous Fungi - A Clinical Laboratory Handbook, 1st ed. Star Publishing Company, Belmont, California.
2202. Sutton, D. A., A. W. Fothergill, and M. G. Rinaldi (ed.). 1998. Guide to Clinically Significant Fungi, 1st ed. Williams & Wilkins, Baltimore.
|
|
|
 |
 |
Home |
Image Bank |
Lecture Bank |
Knowledgebase |
Site Map |
Contact Us |
The Fungi |
Mycoses |
Drugs |
Laboratory |
Education & Tools |
About Us
|
|
|
|